The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · cited 1×
“ILB4 stains microglia selectively in brain and is used frequently as a marker for microglial activation in studies of neural damage, trauma, and neurodegeneration (Kreutzberg, 1996; Pocock and Liddle, 2001; Wyss-Coray and Mucke, 2002).”
BackgroundWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 2×
“MPTP is known to cause microglial activation (Czlonkowska et al., 1996; Du et al., 2001; Wu et al., 2002), so we tested it in comparison with methamphetamine, which does not cause damage to DA cell bodies (Harvey et al., 2000b).”
BackgroundLehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Microglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Beyond Phrenology: What Can Neuroimaging Tell Us About Distributed Circuitry?
Friston, K. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142846 · Cited by 465
Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer, J. F., Davies, D. L., Schmued, L., Broening, H. W., Newport, G. D., Slikker, W., & Holson, R. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38650-7 · Cited by 411
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.
O'Callaghan, J. P., & Miller, D. B. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22433-8 · Cited by 409
Streit, W. J. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.11.2212623 · Cited by 375
Tsutsui, S., Schnermann, J., Noorbakhsh, F., Henry, S., Yong, V. W., Winston, B. W., Warren, K., & Power, C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4271-03.2004 · Cited by 323
Cadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Miller, D. B., & O'Callaghan, J. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 259
Depino, A. M., Earl, C., Kaczmarczyk, E., Ferrari, C., Besedovsky, H., Del Rey, A., Pitossi, F. J., & Oertel, W. H. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03014.x · Cited by 236
Reciprocal Interactions Between Microglia and Neurons: From Survival to Neuropathology
Polazzi, E., & Contestabile, A. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.3.221 · Cited by 233
Microglia in neurodegeneration: Molecular aspects
Gebicke‐Haerter, P. J. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1120 · Cited by 212
Ali, S. F., Newport, G. D., Holson, R. R., Slikker, W., & Bowyer, J. F. (1994) · Brain Research · doi:10.1016/s0006-8993(09)90007-5 · Cited by 205
Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity
LaVoie, M. J., Card, J. P., & Hastings, T. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.010 · Cited by 204
Schwarzschild, M. A., Xu, K., Öztaş, E., Petzer, J. P., Castagnoli, K., Castagnoli, N. J., & Chen, J. (2003) · Neurology · doi:10.1212/01.wnl.0000095214.53646.72 · Cited by 133
Evidence for functional adenosine A3 receptors in microglia cells
Hammarberg, C., Schulte, G., & Fredholm, B. B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01919.x · Cited by 131
Harvey, D. C., Laćan, G., Tanious, S. P., & Melega, W. P. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02439-2 · Cited by 127
Increased Morphological Diversity of Microglia in the Activated Hypothalamic Supraoptic Nucleus
Ayoub, A. E., & Salm, A. K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07759.2003 · Cited by 122
Maragos, W. F., Young, K. L., Turchan-Cholewo, J. T., Guseva, M., Pauly, J. R., Nath, A., & Cass, W. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01212.x · Cited by 117
Hirata, H., Ladenheim, B., Carlson, E. J., Epstein, C. J., & Cadet, J. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01502-7 · Cited by 117
Stress-induced hyperthermia as a putative anxiety model
Zethof, T. J. J., der Heyden, J. A. M. V., Tolboom, J. T. B. M., & Olivier, B. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00520-x · Cited by 115
Patterns of Selective Neuronal Damage in Methamphetamine-User AIDS Patients
Langford, D., Adame, A., Grigorian, A., Grant, I., McCutchan, J. A., Ellis, R. J., Marcotte, T. D., & Masliah, E. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200312150-00004 · Cited by 114
Cass, W. A., Harned, M. E., Peters, L. E., Nath, A., & Maragos, W. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03122-6 · Cited by 100
Metzger, R. R., Haughey, H. M., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39008-1 · Cited by 94
Microglial signalling cascades in neurodegenerative disease
Pocock, J. M., & Liddle, A. C. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32103-9 · Cited by 91
Thomas, D. M., Francescutti, D. M., Liu, X., & Kuhn, D. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02182.x · Cited by 91
Self-citationBaucum, A. J., Rau, K. S., Riddle, E. L., Hanson, G. R., & Fleckenstein, A. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0387-04.2004 · Cited by 91
Gras, G. S., Chrétien, F., Decouvelaere, A., Pavec, G. L., Porcheray, F., Bossuet, C., Léone, C., Mialocq, P., Dereuddre‐Bosquet, N., Clayette, P., et al. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00020.x · Cited by 68
Harvey, D. C., Laćan, G., & Melega, W. P. (2000) · Experimental Brain Research · doi:10.1007/s002210000386 · Cited by 60
Donne, K. T. D., & Sonsalla, P. K. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24014-9 · Cited by 55
Haughey, H. M., Fleckenstein, A. E., & Hanson, G. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720661.x · Cited by 47
MK-801 prevents microglial reaction in rat hippocampus after forebrain ischemia
Streit, W. J., Morioka, T., & Kalehua, A. N. (1992) · Neuroreport · doi:10.1097/00001756-199202000-00006 · Cited by 40
Productive HIV-2 infection in the brain is restricted to macrophages/microglia
Mörner, A., Thomas, J. A., Björling, E., Munson, P., Lucas, S. B., & McKnight, Á. (2003) · AIDS · doi:10.1097/00002030-200307040-00005 · Cited by 28
Cited by
Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González‐Gallego, J. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 626
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Synuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 430
Methamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381
Metadata
- Authors
- Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 311
- Issue
- 1
- Pages
- 1-7
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2160588949
- Cited by
- 315
- References
- 41
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.